Celldex Therapeutics buy Wells Fargo & Company
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€32.67
Performance (%)
48.91%
Price
23.03.26
€26.60
Summary
This prediction is currently active. With a performance of 48.91% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 3.101% | 3.101% |
| iShares Core DAX® | -3.509% | -8.747% |
| iShares Nasdaq 100 | -2.782% | -0.632% |
| iShares Nikkei 225® | -2.038% | -6.841% |
| iShares S&P 500 | -2.598% | -2.230% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat